Gyl Financial Synergies, LLC Abbott Laboratories Transaction History

Gyl Financial Synergies, LLC

$1.31 Billion
Q3 2024

A detailed history of Gyl Financial Synergies, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Gyl Financial Synergies, LLC holds 15,377 shares of ABT stock, worth $1.82 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

15,377

Previous 15,385 0.05%

Holding current value

$1.82 Million

Previous $1.6 Million 9.7%

% of portfolio

0.13%

Previous 0.13%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$100.07 - $118.13 $800 - $945	-8 Reduced 0.05%	15,377 $1.75 Million
Q2 2024 Jul 23, 2024	SELL	$100.73 - $112.44 $70,007 - $78,145	-695 Reduced 4.32%	15,385 $1.6 Million
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $7,118 - $7,862	-65 Reduced 0.4%	16,080 $1.83 Million
Q4 2023 Feb 09, 2024	SELL	$90.19 - $110.4 $45,275 - $55,420	-502 Reduced 3.02%	16,145 $1.78 Million
Q3 2023 Nov 06, 2023	SELL	$95.53 - $114.62 $27,417 - $32,895	-287 Reduced 1.69%	16,647 $1.61 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $549,452 - $612,205	5,452 Added 47.48%	16,934 $1.85 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $735,264 - $865,449	7,591 Added 195.09%	11,482 $1.16 Million
Q4 2022 Feb 06, 2023	BUY	$95.06 - $111.52 $46,674 - $54,756	491 Added 14.44%	3,891 $427,000
Q3 2022 Nov 01, 2022	SELL	$96.76 - $112.03 $82,826 - $95,897	-856 Reduced 20.11%	3,400 $329,000
Q2 2022 Aug 01, 2022	SELL	$102.07 - $123.37 $93,700 - $113,253	-918 Reduced 17.74%	4,256 $462,000
Q1 2022 May 05, 2022	SELL	$114.02 - $139.04 $207,630 - $253,191	-1,821 Reduced 26.03%	5,174 $612,000
Q4 2021 Feb 08, 2022	BUY	$115.53 - $141.46 $116,454 - $142,591	1,008 Added 16.84%	6,995 $984,000
Q3 2021 Nov 01, 2021	BUY	$116.66 - $129.06 $17,382 - $19,229	149 Added 2.55%	5,987 $707,000
Q2 2021 Aug 02, 2021	BUY	$105.79 - $124.53 $3,385 - $3,984	32 Added 0.55%	5,838 $677,000
Q1 2021 May 04, 2021	BUY	$108.84 - $128.23 $870 - $1,025	8 Added 0.14%	5,806 $696,000
Q4 2020 Feb 02, 2021	BUY	$105.0 - $114.42 $53,025 - $57,782	505 Added 9.54%	5,798 $635,000
Q3 2020 Nov 06, 2020	BUY	$91.64 - $111.29 $18,602 - $22,591	203 Added 3.99%	5,293 $576,000
Q2 2020 Aug 04, 2020	SELL	$76.57 - $98.0 $2,603 - $3,332	-34 Reduced 0.66%	5,090 $465,000
Q1 2020 May 05, 2020	BUY	$62.82 - $91.86 $60,495 - $88,461	963 Added 23.14%	5,124 $404,000
Q4 2019 Feb 06, 2020	SELL	$78.51 - $87.4 $14,131 - $15,732	-180 Reduced 4.15%	4,161 $361,000
Q3 2019 Nov 12, 2019	BUY	$81.84 - $88.74 $6,710 - $7,276	82 Added 1.93%	4,341 $363,000
Q2 2019 Aug 09, 2019	SELL	$72.88 - $85.0 $28,204 - $32,895	-387 Reduced 8.33%	4,259 $358,000
Q1 2019 May 21, 2019	SELL	$66.22 - $80.06 $1.07 Million - $1.3 Million	-16,194 Reduced 77.71%	4,646 $371,000
Q1 2019 May 14, 2019	BUY	$66.22 - $80.06 $1.06 Million - $1.28 Million	16,030 Added 333.26%	20,840 $1.67 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $315,343 - $357,238	4,810 New	4,810 $348,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gyl Financial Synergies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gyl Financial Synergies, LLC with notifications on news.

Account

Gyl Financial Synergies, LLC Abbott Laboratories Transaction History